Nuclear factor-κB1 controls the functional maturation of dendritic cells and prevents the activation of autoreactive T cells

Nature Medicine

Volumn 17, Issue 12, 2011, Pages 1663-1667

  Dissanayake, Dilan ^a,b   Hall, Håkan ^a   Berg Brown, Nancy ^a   Elford, Alisha R ^a   Hamilton, Sara R ^a   Murakami, Kiichi ^a   Deluca, Leslie Summers ^b   Gommerman, Jennifer L ^b   Ohashi, Pamela S ^a,b  

^a PRINCESS MARGARET HOSPITAL   (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

GRANZYME B; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; NUCLEAR FACTOR KAPPA B 1; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ANIMAL CELL; ANTIGEN PRESENTATION; ARTICLE; AUTOIMMUNITY; CD8+ T LYMPHOCYTE; CELL MATURATION; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOTOXIC T LYMPHOCYTE; DENDRITIC CELL; DIABETES MELLITUS; IN VIVO STUDY; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; T LYMPHOCYTE ACTIVATION;

ADAPTIVE IMMUNITY; ANIMALS; AUTOANTIGENS; AUTOIMMUNITY; CD8-POSITIVE T-LYMPHOCYTES; DENDRITIC CELLS; FLOW CYTOMETRY; GENE EXPRESSION REGULATION; GRANZYMES; IMMUNOHISTOCHEMISTRY; LYMPHOCYTE ACTIVATION; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; NF-KAPPA B; T-LYMPHOCYTES, CYTOTOXIC; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84855534980     PISSN: 10788956     EISSN: 1546170X     Source Type: Journal    
DOI: 10.1038/nm.2556     Document Type: Article

References (38)

1. Fujikado N. et al. Dcir deficiency causes development of autoimmune diseases in mice due to excess expansion of dendritic cells. Nat. Med. 14, 176-180 (2008). (Pubitemid 351214549)
2. Stranges P.B. et al. Elimination of antigen-presenting cells and autoreactive T cells by Fas contributes to prevention of autoimmunity. Immunity 26, 629-641 (2007). (Pubitemid 46756349)
3. Chen M. et al. Dendritic cell apoptosis in the maintenance of immune tolerance. Science 311, 1160-1164 (2006).
4. Deane J.A. et al. Control of Toll-like receptor 7 expression is essential to restrict autoimmunity and dendritic cell proliferation. Immunity 27, 801-810 (2007). (Pubitemid 350102256)
5. Blanco P., Palucka A.K., Gill M., Pascual V. & Banchereau J. Induction of dendritic cell differentiation by IFN-α in systemic lupus erythematosus. Science 294, 1540-1543 (2001). (Pubitemid 33063928)
6. Sha W.C., Liou H.C., Tuomanen E.I. & Baltimore D. Targeted disruption of the p50 subunit of NF-κB leads to multifocal defects in immune responses. Cell 80, 321-330 (1995).
7. Hilliard B., Samoilova E.B., Liu T.S., Rostami A. & Chen Y. Experimental autoimmune encephalomyelitis in NF-κB-deficient mice: Roles of NF-κB in the activation and differentiation of autoreactive T cells. J. Immunol. 163, 2937-2943 (1999). (Pubitemid 29399226)
8. Campbell I.K., Gerondakis S., O'Donnell K. & Wicks I.P. Distinct roles for the NF-κB1 (p50) and c-Rel transcription factors in inflammatory arthritis. J. Clin. Invest. 105, 1799-1806 (2000). (Pubitemid 30421761)
9. Bohuslav J. et al. Regulation of an essential innate immune response by the p50 subunit of NF-κB. J. Clin. Invest. 102, 1645-1652 (1998). (Pubitemid 28516249)
10. Carmody R.J., Ruan Q., Palmer S., Hilliard B. & Chen Y.H. Negative regulation of toll-like receptor signaling by NF-κB p50 ubiquitination blockade. Science 317, 675-678 (2007). (Pubitemid 47229968)
11. Ohashi P.S. et al. Ablation of "tolerance" and induction of diabetes by virus infection in viral antigen transgenic mice. Cell 65, 305-317 (1991). (Pubitemid 121006060)
12. Garza K.M. et al. Role of antigen-presenting cells in mediating tolerance and autoimmunity. J. Exp. Med. 191, 2021-2027 (2000). (Pubitemid 30390363)
13. Kyburz D. et al. T cell immunity after a viral infection versus T cell tolerance induced by soluble viral peptides. Eur. J. Immunol. 23, 1956-1962 (1993). (Pubitemid 23236793)
14. Weih F. et al. p50-NF-κB complexes partially compensate for the absence of RelB: Severely increased pathology in p50-/-relB-/-double-knockout mice. J. Exp. Med. 185, 1359-1370 (1997). (Pubitemid 27172916)
15. Zhao J., Freeman G.J., Gray G.S., Nadler L.M. & Glimcher L.H. A cell type-specific enhancer in the human B7.1 gene regulated by NF-κB. J. Exp. Med. 183, 777-789 (1996). (Pubitemid 26113950)
16. De Cesaris P. et al. Tumor necrosis factor-a induces interleukin-6 production and integrin ligand expression by distinct transduction pathways. J. Biol. Chem. 273, 7566-7571 (1998). (Pubitemid 28152783)
17. Reis e Sousa C. Dendritic cells in a mature age. Nat. Rev. Immunol. 6, 476-483 (2006).
18. Mariathasan S. et al. Differential activation of the inflammasome by caspase-1 adaptors ASC and Ipaf. Nature 430, 213-218 (2004). (Pubitemid 38902430)
19. Chu C.Q., Field M., Feldmann M. & Maini R.N. Localization of tumor necrosis factor alpha in synovial tissues and at the cartilage-pannus junction in patients with rheumatoid arthritis. Arthritis Rheum. 34, 1125-1132 (1991).
20. Sharief M.K. & Hentges R. Association between tumor necrosis factor-alpha and disease progression in patients with multiple sclerosis. N. Engl. J. Med. 325, 467-472 (1991).
21. Cavallo M.G. et al. Cytokines in sera from insulin-dependent diabetic patients at diagnosis. Clin. Exp. Immunol. 86, 256-259 (1991).
22. Thomas H.E., Trapani J.A. & Kay T.W. The role of perforin and granzymes in diabetes. Cell Death Differ. 17, 577-585 (2010).
23. Kim S. et al. NF-κB prevents beta cell death and autoimmune diabetes in NOD mice. Proc. Natl. Acad. Sci. USA 104, 1913-1918 (2007). (Pubitemid 46239878)
24. Weaver Jr. D.J. et al. Dendritic cells from nonobese diabetic mice exhibit a defect in NF-κB regulation due to a hyperactive I κB kinase. J. Immunol. 167, 1461-1468 (2001).
25. Poligone B., Weaver D.J. Jr., Sen P., Baldwin A.S. Jr. & Tisch R. Elevated NF-κB activation in nonobese diabetic mouse dendritic cells results in enhanced APC function. J. Immunol. 168, 188-196 (2002). (Pubitemid 34014118)
26. Wheat W. et al. Increased NF-κB activity in B cells and bone marrow-derived dendritic cells from NOD mice. Eur. J. Immunol. 34, 1395-1404 (2004). (Pubitemid 39256019)
27. Ma L. et al. Prevention of diabetes in NOD mice by administration of dendritic cells deficient in nuclear transcription factor-κB activity. Diabetes 52, 1976-1985 (2003). (Pubitemid 36919789)
28. Mollah Z.U. et al. Abnormal NF-κB function characterizes human type 1 diabetes dendritic cells and monocytes. J. Immunol. 180, 3166-3175 (2008).
29. Kang S.M., Tran A.C., Grilli M. & Lenardo M.J. NF-κB subunit regulation in nontransformed CD4+ T lymphocytes. Science 256, 1452-1456 (1992).
30. Zhong H., May M.J., Jimi E. & Ghosh S. The phosphorylation status of nuclear NF-κB determines its association with CBP/p300 or HDAC-1. Mol. Cell 9, 625-636 (2002). (Pubitemid 34273792)
31. Saccani S., Pantano S. & Natoli G. Modulation of NF-κB activity by exchange of dimers. Mol. Cell 11, 1563-1574 (2003). (Pubitemid 36776542)
32. Ruan Q., Zheng S.J., Palmer S., Carmody R.J. & Chen Y.H. Roles of Bcl-3 in the pathogenesis of murine type 1 diabetes. Diabetes 59, 2549-2557 (2010).
33. Udalova I.A. et al. Functional consequences of a polymorphism affecting NF-κB p50-p50 binding to the TNF promoter region. Mol. Cell. Biol. 20, 9113-9119 (2000). (Pubitemid 32246100)
34. Date Y. et al. Identification of a genetic risk factor for systemic juvenile rheumatoid arthritis in the 5'-flanking region of the TNFa gene and HLA genes. Arthritis Rheum. 42, 2577-2582 (1999). (Pubitemid 30327174)
35. Li N. et al. Association of tumour necrosis factor a (TNF-α) polymorphisms with Graves' disease: A meta-analysis. Clin. Biochem. 41, 881-886 (2008).
36. Stayoussef M. et al. Identification of specific tumor necrosis factor-a-susceptible and -protective haplotypes associated with the risk of type 1 diabetes. Eur. Cytokine Netw. 21, 285-291 (2010).
37. Corvol J.C. et al. Abrogation of T cell quiescence characterizes patients at high risk for multiple sclerosis after the initial neurological event. Proc. Natl. Acad. Sci. USA 105, 11839-11844 (2008).
38. Ouyang W., Beckett O., Flavell R.A. & Li M.O. An essential role of the Forkhead-box transcription factor Foxo1 in control of T cell homeostasis and tolerance. Immunity 30, 358-371 (2009).